A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 8417382)

Published in N Engl J Med on January 21, 1993

Authors

J S Schroeder1, S Z Gao, E L Alderman, S A Hunt, I Johnstone, D B Boothroyd, V Wiederhold, E B Stinson

Author Affiliations

1: Division of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305.

Articles citing this

Aortic pulse pressure is associated with the localization of coronary artery disease based on coronary flow lateralization. Am J Hypertens (2012) 1.42

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis. Croat Med J (2014) 0.81

New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J (1995) 0.80

Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications. World J Transplant (2014) 0.79

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med (2000) 0.79

The challenge of rejection and cardiac allograft vasculopathy. Heart Fail Rev (2001) 0.78

How do calcium channel blockers prevent cardiovascular events. Are they all alike? Drugs (1996) 0.78

Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets. Endocrinol Metab Clin North Am (2007) 0.77

Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy. Circ Heart Fail (2013) 0.76

Advanced therapies for end-stage heart failure. Curr Cardiol Rev (2015) 0.75

Diagnosis and management of coronary allograft vasculopathy in children and adolescents. World J Transplant (2014) 0.75

Heart transplantation: review. Einstein (Sao Paulo) (2015) 0.75

Diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med (1993) 0.75

Immunosuppression in Pediatric Heart Transplantation: 2003 and Beyond. Curr Treat Options Cardiovasc Med (2003) 0.75

Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. J Am Coll Cardiol (2017) 0.75

Articles by these authors

Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2001) 4.89

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation (2001) 4.24

Randomised, controlled trial of efficacy of midwife-managed care. Lancet (1996) 4.21

Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation (1983) 3.99

Management of acute aortic dissections. Ann Thorac Surg (1970) 3.66

Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med (1974) 2.89

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 2.87

The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med (1994) 2.86

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation (1994) 2.50

Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg (1975) 2.43

The cardiac donor. Surg Gynecol Obstet (1971) 2.39

Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37

Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28

Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26

A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20

Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09

Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol (1988) 2.06

Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation (1992) 2.04

Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis (1981) 2.03

Mitral valve prolapse in one hundred presumably healthy young females. Circulation (1976) 2.02

Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01

Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95

Multiple valve replacement with the fresh aortic homograft. J Thorac Cardiovasc Surg (1968) 1.90

The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain (1996) 1.89

Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg (1990) 1.88

Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87

Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82

Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75

The influence of volumetric tumor doubling time, DNA ploidy, and histologic grade on the survival of patients with intracranial astrocytomas. AJNR Am J Neuroradiol (1995) 1.74

Cardiac transplantation in man. 3. Surgical aspects. Am J Surg (1969) 1.72

Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70

Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation (1979) 1.70

Coronary artery size and dilating capacity in ultradistance runners. Circulation (1993) 1.68

Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65

Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62

Primary cardiac neoplasms. Early and late results of surgical treatment in 42 patients. J Thorac Cardiovasc Surg (1987) 1.60

Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant (1996) 1.60

Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol (1995) 1.58

Operative treatment of aortic dissections. Experience with 125 patients over a sixteen-year period. J Thorac Cardiovasc Surg (1979) 1.57

Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant (1996) 1.54

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation (1999) 1.52

New technique for treatment of unstable distal femur fractures by locked double-plating: case report and biomechanical evaluation. J Trauma (2000) 1.50

Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49

Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol (1990) 1.49

Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg (1973) 1.49

Heart and lung transplantation: autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg (1980) 1.47

Long-term experience with porcine aortic valve xenografts. J Thorac Cardiovasc Surg (1977) 1.47

Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass. Circulation (1999) 1.47

Surgical management of aortic dissection during a 30-year period. Circulation (1995) 1.46

Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant (2007) 1.46

Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg (1977) 1.45

Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med (1983) 1.45

Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44

Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation (1994) 1.43

Effects of the pericardium on left ventricular diastolic filling and systolic performance early after cardiac operations. J Thorac Cardiovasc Surg (1992) 1.43

Hemodynamic observations one and two years after cardiac transplantation in man. Circulation (1972) 1.42

Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol (1991) 1.42

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. Eur Heart J (1997) 1.41

Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med (1971) 1.40

Infectious complications in heart-lung transplant recipients. Am J Med (1985) 1.40

Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers. Circulation (1975) 1.40

Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med (2001) 1.39

Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol (1980) 1.39

Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg (1979) 1.39

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med (1987) 1.38

Late benefit of coronary surgery on mortality from myocardial infarction. Circulation (1991) 1.38

Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Am Heart J (2000) 1.38

Echocardiographic findings in discrete subvalvular aortic stenosis. Circulation (1974) 1.38

Changes in diastolic stiffness and tone of the left ventricle during angina pectoris. Circulation (1974) 1.37

Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS) Int J Cardiol (1989) 1.37

Alterations in left ventricular twist mechanics with inotropic stimulation and volume loading in human subjects. Circulation (1994) 1.37

Relation between longitudinal, circumferential, and oblique shortening and torsional deformation in the left ventricle of the transplanted human heart. Circ Res (1989) 1.35

Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. Br Heart J (1975) 1.35

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34

The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant (1989) 1.34

Cardiac homotransplantation. Curr Probl Surg (1979) 1.33

Percutaneous transvenous endomyocardial biopsy. JAMA (1973) 1.33

Nocardia infection in heart transplant patients. Ann Intern Med (1975) 1.31

Exercise response of the denervated heart in long-term cardiac transplant recipients. Am J Cardiol (1980) 1.31

Institutional differences in therapeutic decision making in the Coronary Artery Surgery Study (CASS). Med Decis Making (1986) 1.31

Sequential studies of left ventricular function and wall motion after coronary arterial bypass surgery. Am J Cardiol (1980) 1.31

Surgical treatment of postinfarction ventricular septal defects. Ann Thorac Surg (1969) 1.30